Rapamycin
An mTOR inhibitor studied in longevity research, considered under close clinical oversight.
Not available yet · be first to know when it launches
Rapamycin
Rapamycin is an mTOR inhibitor that has drawn interest in longevity research. Any use for healthy aging is off-label and not FDA-approved for that purpose; we consider it only for eligible patients under close clinical oversight and monitoring.
What it may help support
- Explored in longevity research (not a proven anti-aging treatment)
Delivery
An oral medication, used strictly as directed with clinical monitoring.
Is it right for you?
Adults exploring longevity-focused care who can commit to monitoring. See NAD+ therapy.
An honest word on the evidence
Off-label for healthy-aging use and not FDA-approved for longevity. Evidence in humans for anti-aging benefit is early. We keep it clinician-led with close monitoring and realistic expectations. Results vary.
How it works here
Every plan follows one path. Each step feeds the next. See the NAD+ Therapy approach.
- 01
Measure
We baseline your labs, history, and goals.
- 02
Plan
A clinician decides whether this fits — and what else might serve you.
- 03
Act
If appropriate, you start with clear guidance and high-touch support.
- 04
Track
We monitor how you respond on a defined cadence.
- 05
Adjust
Protocols are refined over time. Guided care, not a kit in the mail.
Frequently asked questions
No. It is FDA-approved for other uses; longevity use is off-label and considered only under clinical oversight.
Yes. It affects the immune system and requires eligibility screening and monitoring. It isn't right for everyone.
Rapamycin is on the way
We're finalizing this treatment now. Join the waitlist and we'll email you the moment it's available — no spam, just the launch.
We measure first. Then we act.
ACT 2 Health provides clinician-led care. Treatments described are available only to eligible patients following clinical evaluation and within applicable regulations. This page is educational and is not medical advice. Individual results vary.